Cargando empresa
Just reported
Q3 2026 results
From LifeStance Health's results release of 5 de noviembre de 2026; its quarterly report has since been filed.
Revenue
Actual
455,9M US$
+25 % y/y
+4,7 % q/qGuided
430M US$
midpoint
Above guide+6,0 %Operating income, GAAP
Actual
33,1M US$
+346 % y/y
+7,9 % q/qGuided
—
No guide given
Company outlook
Q4 2026
- Revenue446M US$ – 466M US$+19 % y/y First given
Full year 2026
- Revenue1,741B US$ – 1,761B US$+23 % y/y Raised +2,7 %
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes LifeStance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.23,3B US$A+
EHCEncompass Health Corporation14B US$A+
ENSGEnsign Group, Inc.10,9B US$A
PACSPACS Group, Inc.7,9B US$A
CONConcentra Group Holdings Parent, Inc.5,5B US$A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
BIIBBiogen Inc.28 oct 2026BAGraded B, now A
Estados financieros completos →
Construido a partir de los propios informes de LifeStance Health Group, Inc. ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.
